Groundbreaking Randomized Controlled Trial Reports Promising Results For Heart Transplant Patients

Groundbreaking Trial Shows Promising Results for Heart Transplant Patients Using CytoSorb.

This post includes affiliate links. If you purchase anything through these affiliated links, the author/website may earn a commission.

A groundbreaking randomized controlled trial has reported excellent clinical outcomes using CytoSorb in heart transplant patients. The study, conducted by CytoSorbents Corporation (NASDAQ: CTSO), showed that the use of Cy…